Journal of Mucosal Immunology Research
Open Access

Immunometabolism; Immune cells; Metabolic pathways; Warburg effect; Metabolic dysregulation; Chronic inflammation; Immune activation; Therapeutic opportunities; Autoimmune disorders

Introduction

The intricate interplay between immunology and metabolism has emerged as a fascinating and increasingly important area of biomedical research. Traditionally, these two fields have been studied in isolation, with immunologists focusing on the immune system’s role in defending against pathogens and maintaining tissue homeostasis, and metabolic researchers investigating the regulation of energy production and nutrient utilization within cells and tissues [1,2]. However, it has become increasingly clear that these seemingly distinct physiological systems are deeply interconnected, influencing each other in ways that significantly impact health and disease. The concept of immunometabolism has been proposed to describe this intersection between immunology and metabolism, highlighting the mutual dependency and regulation between immune responses and metabolic pathways. Immune cells, such as T cells, B cells, and macrophages, require specific metabolic programs to support their various functions, including proliferation, differentiation, and effector responses. Conversely, metabolic processes are modulated by immune signals and cytokines, allowing the body to adapt its metabolic state to meet the demands of immune activation and inflammation [3,4]. One of the most striking examples of this metabolic regulation is the Warburg effect observed in activated T cells, where cells shift from oxidative phosphorylation to aerobic glycolysis to support their rapid proliferation and cytokine production. Similarly, macrophages exhibit metabolic plasticity, switching between glycolytic and oxidative metabolism depending on their activation state and the microenvironment. These metabolic adaptations are not merely passive responses to immune activation but actively shape immune cell function and fate, influencing the outcome of immune responses and disease progression. The implications of immunometabolism extend beyond immune cell biology to encompass a wide range of diseases, including cancer, autoimmune disorders, infectious diseases, and metabolic syndrome. Metabolic dysregulation, often observed in conditions such as obesity, diabetes, and cardiovascular disease, can profoundly affect immune cell function and contribute to disease pathogenesis [5]. Conversely, chronic inflammation and immune activation can lead to metabolic alterations, creating a complex interplay that can either promote or mitigate disease progression. In this review, we will explore the current state of knowledge in the field of immunometabolism, focusing on how metabolic pathways and immune responses interact to influence health and disease. We will delve into the metabolic requirements of immune cells, the impact of metabolic dysregulation on immune function, and the potential therapeutic opportunities that arise from understanding this metabolic harmony. By examining the cross-talk between immunology and metabolism, we aim to provide a comprehensive overview of this exciting and rapidly evolving field and highlight its significance for human health [6].

Material and Methods

The immune system and metabolism are two fundamental physiological systems that have traditionally been studied independently. However, growing evidence suggests that they are closely interconnected, with metabolic pathways playing a pivotal role in shaping immune responses. This intersection between immunology and metabolism, often referred to as immunometabolism, offers new insights into the pathophysiology of various diseases, including cancer, autoimmune disorders, and metabolic syndrome.

Metabolic requirements of immune cells

Immune cells, like all cells in the body, require energy and building blocks to function effectively. Unlike other cells, immune cells exhibit remarkable metabolic plasticity, adapting their metabolic pathways to meet the demands of different immune responses [7]. For instance, activated T cells undergo a metabolic switch from oxidative phosphorylation to aerobic glycolysis, a phenomenon known as the Warburg effect. This metabolic reprogramming not only provides the energy needed for proliferation and effector functions but also influences immune cell differentiation and cytokine production.

Metabolic dysregulation and immune responses

Conversely, metabolic dysregulation can profoundly affect immune cell function and contribute to the pathogenesis of various diseases. Obesity, for example, is associated with chronic low-grade inflammation, partly due to alterations in adipose tissue metabolism and the secretion of pro-inflammatory cytokines. Similarly, metabolic disorders like diabetes can impair immune cell function, leading to increased susceptibility to infections and poor wound healing [8]. Understanding these metabolic-immune interactions is crucial for developing targeted interventions to mitigate the adverse effects of metabolic dysregulation on immune responses.

Therapeutic opportunities

The growing understanding of immunometabolism has opened up new avenues for therapeutic intervention. Targeting metabolic pathways in immune cells holds promise for modulating immune responses in a variety of diseases. For instance, inhibitors of glycolytic enzymes or mitochondrial metabolism have been explored as potential immunomodulatory agents for treating autoimmune disorders and cancer. Additionally, dietary interventions and metabolic modulators are being investigated for their ability to improve metabolic health and enhance immune function [9].

Results

The exploration of immunometabolism has yielded significant insights into the interplay between immune responses and metabolic pathways. Immune cells, such as T cells and macrophages, exhibit distinct metabolic profiles that are tailored to their functional roles. Activated T cells predominantly rely on aerobic glycolysis to support proliferation and cytokine production, while macrophages can switch between glycolysis and oxidative phosphorylation depending on their activation state. Metabolic dysregulation, often observed in conditions like obesity and diabetes, has been shown to impair immune cell function and contribute to disease pathogenesis. For instance, obesityinduced inflammation is partly mediated by alterations in adipose tissue metabolism, leading to increased secretion of pro-inflammatory cytokines like TNF-α and IL-6. Similarly, individuals with diabetes often exhibit compromised immune responses, characterized by impaired T cell function and increased susceptibility to infections. Therapeutically, targeting metabolic pathways in immune cells has shown promise in modulating immune responses and improving disease outcomes. Small molecule inhibitors of glycolytic enzymes and mitochondrial metabolism have been explored as potential immunomodulatory agents. Additionally, dietary interventions aimed at improving metabolic health, such as caloric restriction and ketogenic diets, have been shown to enhance immune function and reduce inflammation in preclinical models. Overall, the results highlight the intricate relationship between immunology and metabolism and its profound impact on health and disease. Understanding these metabolic-immune interactions offers new opportunities for developing targeted therapies that can modulate immune responses and improve metabolic health. Further research in this exciting field is warranted to unravel the complexities of metabolic harmony and its implications for human health.

Discussion

The findings from studies on immunometabolism underscore the importance of metabolic homeostasis in regulating immune responses and maintaining overall health. The ability of immune cells to adapt their metabolic profiles in response to environmental cues highlights their remarkable plasticity and versatility. This metabolic flexibility is essential for mounting effective immune responses against pathogens and maintaining immune surveillance against cancer cells. However, the flip side of this metabolic adaptability is the susceptibility of immune cells to metabolic dysregulation, which can compromise their function and contribute to disease progression. Obesity, diabetes, and other metabolic disorders not only affect systemic metabolism but also create a pro-inflammatory environment that further exacerbates immune dysfunction. This vicious cycle of metabolic and immune dysregulation underscores the need for integrated approaches that target both metabolic and immunological pathways [10]. The therapeutic potential of modulating immunometabolism is promising but comes with its own set of challenges. While small molecule inhibitors and dietary interventions have shown efficacy in preclinical models, translating these findings into effective treatments for human diseases remains a complex task. Factors such as metabolic heterogeneity among individuals, potential side effects of metabolic modulators, and the dynamic nature of immune responses pose significant challenges for therapeutic development. Despite these challenges, the growing body of evidence linking immunology and metabolism offers exciting opportunities for innovative research and therapeutic strategies. Collaborative efforts between immunologists and metabolic researchers will be crucial for advancing our understanding of metabolic harmony and harnessing its therapeutic potential. Future studies should focus on identifying novel metabolic targets, optimizing therapeutic interventions, and conducting rigorous clinical trials to validate the efficacy and safety of immunometabolic therapies. In doing so, we can hope to unlock new avenues for treating a wide range of diseases and improving the quality of life for millions of people worldwide.

Conclusion

The burgeoning field of immunometabolism has provided compelling evidence for the intricate relationship between immunology and metabolism, highlighting their intertwined roles in health and disease. Immune cells exhibit remarkable metabolic plasticity, adapting their metabolic profiles to meet the demands of immune activation and inflammation. This metabolic flexibility is essential for mounting effective immune responses against pathogens and maintaining immune homeostasis. Conversely, metabolic dysregulation can profoundly affect immune cell function, contributing to the pathogenesis of various diseases, including cancer, autoimmune disorders, and metabolic syndrome. Obesity, diabetes, and other metabolic disorders create a pro-inflammatory environment that exacerbates immune dysfunction, creating a vicious cycle of metabolic and immune dysregulation. The therapeutic potential of targeting immunometabolism is promising but comes with challenges, including metabolic heterogeneity among individuals and potential side effects of metabolic modulators. Despite these challenges, the growing understanding of immunometabolism offers exciting opportunities for developing innovative therapeutic strategies that can modulate immune responses and improve metabolic health. In conclusion, the cross-talk between immunology and metabolism plays a critical role in shaping immune responses and influencing disease outcomes. By unraveling the complexities of metabolic harmony between immune cells and their microenvironment, we can pave the way for targeted interventions that address both immunological and metabolic pathways. Future research in this exciting field is warranted to identify novel metabolic targets, optimize therapeutic interventions, and validate the efficacy and safety of immunometabolic therapies. Through collaborative efforts and interdisciplinary research, we can hope to unlock new avenues for treating a wide range of diseases and improving the quality of life for millions of people worldwide.

1. De Zoete MR, Palm NW, Zhu S, Flavell RA (2014)Inflammasomes. Cold Spring Harb Perspect Biol 6: a016287.

Google Scholar

2. Latz E, Xiao TS, Stutz A (2013)Activation and regulation of the inflammasomes. Nat Rev Immunol 13: 397-411.

Indexed at, Google Scholar, Crossref

3. Miao EA, Rajan JV, Aderem A (2011)Caspase-1- induced pyroptotic cell death. Immunol Rev 243: 206-214.

Indexed at, Google Scholar, Crossref

4. Sansonetti PJ, Phalipon A, Arondel J, Thirumalai K, Banerjee S, et al. (2000)Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 12: 581-590.

Indexed at, Google Scholar, Crossref

5. Vajjhala PR, Mirams RE, Hill JM (2012)Multiple binding sites on the pyrin domain of ASC protein allow self-association and interaction with NLRP3 protein. J Biol Chem 287: 41732-41743.

Indexed at, Google Scholar, Crossref

6. Proell M, Gerlic M, Mace PD, Reed JC, Riedl SJ (2013)The CARD plays a critical role in ASC foci formation and inflammasome signalling. Biochem J 449: 613-621.

Indexed at, Google Scholar, Crossref

7. Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, et al. (2008)The NLR gene family: a standard nomenclature. Immunity 28: 285-287.

Indexed at, Google Scholar, Crossref

8. Fernandes-Alnemri T, Wu J, Yu JW, Datta P, Miller B, et al. (2007)The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ 14:1590-1604.

Indexed at, Google Scholar, Crossref

9. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE (2006)Nod-like proteins in immunity, inflammation and disease. Nat Immunol 7:1250-1257.

Indexed at, Google Scholar, Crossref

10. Pallone F, Monteleone G (1998)Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut 43: 735-736.

Indexed at, Google Scholar, Crossref